Process evaluation of a pharmacogenomic informed antidepressant prescribing intervention delivered in primary care: findings from the PRESIDE (PhaRmacogEnomicS in Depression) trial.
Pharmacogenomics · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansAntidepressive AgentsPrimary Health CarePharmacogeneticsFemaleMajor Depressive DisorderMaleAdultMiddle AgedAustraliaPharmacogenomicsantidepressantsdepressionprimary careprocess evaluation
Come citare questo studio
Georgia Ramsay, Madeline Luke, Philip Ly, Rachel Brooks, Matthew Thoenig, Elise Dettmann, Jennifer Bibb, Floriana La Rocca, Patty Chondros, Cathrine Mihalopoulos, Mary Lou Chatterton, Melanie Galea, Adrian Laughlin, Jane Gunn, Timothy Chen, Thomas M Polasek, Victoria J Palmer, Chad Bousman, Sibel Saya, Jon Emery. (2026). Process evaluation of a pharmacogenomic informed antidepressant prescribing intervention delivered in primary care: findings from the PRESIDE (PhaRmacogEnomicS in Depression) trial.. Pharmacogenomics. DOI: 10.1080/14622416.2026.2736305
Consulta la pubblicazione originale ↗